FDA says it will take “decisive steps” against GLP-1 compounders; Reuters reports HHS refers Hims to US DOJ for investigation Sherwood NewsNVO, LLY Stocks Slide as HIMS Launches $49 Compounded Semaglutide Pill Yahoo FinanceUS health company launches weight-loss pill that Novo Nordisk calls an ‘untested knockoff’ Yahoo News Singapore
